Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Novo Nordisk gears up for December Ozempic launch in India, sources say - 2Feeling wonder every day improves our health. Here’s how to do it.
- 3A top Marine shares his secrets to keeping fit at 50
- 4Russia downs 16 drones heading for Moscow, mayor says
- 5Vote in favor of your #1 Sort of Convenience for a Family
- Why the Houthis waited until now to strike
- What Yogurt Types Do You Know
- Timex Gives Its Classic Affordable Field Watch a Tactical, Milspec Makeover
- Kids get diseases like lupus, too. As researchers hunt better treatments, this camp brings joy
- When does Spotify Wrapped come out? The music streamer says 'soon.'
- In Antarctica, photos show a remote area teeming with life amid growing risks from climate change
- A definitive Handbook for Securities exchange Money management
- Farmers call for French blockades over cow disease cull
- Vote In favor of Your Favored Pet Consideration Administration
